HDL Therapeutics
About:
HDL Therapeutics is a medical device company that develops cardiovascular therapeutic device designed to fight heart disease.
Website: http://hdltherapeutics.com
Description:
HDL Therapeutics have developed the first therapy of its kind to rapidly reverse coronary atherosclerosis in patients with Homozygous Familial Hypercholesterolemia (HoFH).
Total Funding Amount:
$10.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Vero Beach, Florida, United States
Founded Date:
2009-01-01
Contact Email:
info(AT)hdltherapeutics.com
Founders:
Bryan Brewer, Michael Matin
Number of Employees:
1-10
Last Funding Date:
2021-03-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai